Betta Pharmaceuticals (300558) Revenue Breakdown - Main Composition

43.70
+0.45+1.04%

Pre-Opening Auction Mar 16 09:30 CST

18.39BMarket Cap60.61P/E (TTM)

Betta Pharmaceuticals (300558) Revenue Breakdown Overview

By Product

Currency:CNY

2025/H1

Stock NameRevenueRatio

Drug sales1.72B99.10%

Other business15.54M0.90%

By Industry

Currency:CNY

2024/FY

Stock NameRevenueRatio

Pharmaceutical manufacturing2.89B100.00%

By Country/Region

Currency:CNY

2024/FY

Stock NameRevenueRatio

Domestic2.86B98.77%

Abroad35.64M1.23%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Recently, the ongoing conflict between the US and Iran has continued to disrupt the stock market. On March 11 local time, Trump once again s Show More

富哥搞钱

Feb 28 17:22

Breaking! The US and Israel jointly bombed Iran. What will be the stock market trend next week?

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.